Table 1 Data for all 14,551 patients at time of admission by indication and type of hospital
| Â | Femoral fracture patients | Forearm fracture patients | ||
|---|---|---|---|---|
| Â | All hospitals | Acute-care hospitals | Rehabilitation hospitals | Acute-care hospitals |
Number of patients | 12,520 | 3914 (31.3%) | 8606 (68.7%) | 2031 (100%) |
Sex | F: 9580 (76.5%) | F: 2975 (76.0%) | F: 6605 (76.7%) | F: 1658 (81.6%) |
| Â | M: 2940 (23.5%) | M: 939 (24.0%) | M: 2001 (23.3%) | M: 373 (18.4%) |
Age: mean (± SD) | F: 79.1 (9.9) | Comparison acute-care versus rehabilitation facilities: | F: 69.4 (12.3) | |
|  | M: 72.5 (12.9) | F: 81.3 (9.8) versus 78.1 (9.9) Δ = 3.2 years (p < 0.0001) | M: 59.4 (13.8) | |
|  | (p < 0.0001) | M: 73.8 (13.3) versus 71.9 (12.6) Δ = 1.9 years (p < 0.0002) | (p < 0.0001) | |
BMI (kg/m 2 ) | < 25: 56.3% | Acute-care versus rehabilitation: < 25: 60.6% vs. 54.4% | < 25: 42.7% | |
|  | 25–29.9: 32.6% | 25–29.9: 30.8% vs. 33.4% | 25–29.9: 42.2% | |
|  | ≥ 30: 11.1% | ≥ 30: 8.6% vs. 12.2% | ≥ 30: 15.2% | |
| Â | Â | (p < 0.0001) | Â | |
ASA classification | (I) 11.1% | Acute-care versus rehabilitation: (I): 5.3% vs. 13.6% | (I) 28.8% | |
| Â | (II) 46.7% | (II): 34.2% vs. 52.4% | (II) 51.4% | |
| Â | (III) 38.7% | (III): 55.2% vs. 31.3% | (III) 19.1% | |
| Â | (IV+V) 3.6% | (IV+V): 5.3% vs. 2.7% | (IV+V) 3.6% | |
| Â | Â | (p < 0.0001) | Â | |
Presenting fracture (% of all patients) | Proximal femur: 10,865 (86.8%) Distal femur: 138 (1.1%) Combination (usually with radius) or unclassified: 1,517 (12.1%) | Proximal femur: 3623 (92.6%) Distal femur: 27 (0.7%) Combination (usually with radius) or unclassified: 264 (6.7%) | Proximal femur: 7242 (84.2%) Distal femur: 111 (1.3%) Combination (usually with radius) or unclassified: 1253 (14.6%) | F: left arm 58.9%, right arm 39.6%, both arms 1.5% M: left arm 48.4%, right arm 50%, both arms 1.6% |
Previous fracture (% of all patients) | 4010 (32.0%) | 1170 (29.9%) | 2840 (33.0%) | 569 (28.0%) |
Fracture location (% of all patients with a previous fracture, multiple locations possible) | Radius: 11.2% | Radius: 10.4% | Radius: 11.6% | Radius: 12.6% |
| Â | Humerus: 4.5% | Humerus: 4.3% | Humerus: 4.7% | Humerus: 2.8% |
| Â | Vertebra: 4.4% | Vertebra: 3.7% | Vertebra: 4.7% | Vertebra: 2.6% |
| Â | Femur: 7.4% | Femur: 7.2% | Femur: 7.5% | Femur: 3.0% |
| Â | Other: 12.4% | Other: 11.2% | Other: 12.9% | Other: 11.8% |
Low bone density | 33.7% | 25.9% of 792 patients | 37.0% of 1889 patients | 23.4% of 590 patients |
Reported comorbidities (% of all patients, multiple comorbidities possible) | Hypertension: 61.2% | Hypertension: 64.6% | Hypertension: 59.6% | Hypertension: 48.9% |
| Â | Diabetes: 20.5% | Diabetes: 22.6% | Diabetes: 19.5% | Diabetes: 11.3% |
| Â | CHD: 36.0% | CHD: 45.1% | CHD: 31.7% | CHD: 21.2% |
| Â | MI: 7.0% | MI: 7.6% | MI: 6.7% | MI: 3.2% |
| Â | PAD: 13.5% | PAD: 20.7% | PAD: 10.2% | PAD: 8.2% |
| Â | Stroke: 11.8% | Stroke: 14.0% | Stroke: 10.9% | Stroke: 4.8 |
| Â | Arthritis: 34.8% | Arthritis: 30.0% | Arthritis: 36.9% | Arthritis: 23.9% |
| Â | Rheumatism: 5.0% | Rheumatism: 5.4% | Rheumatism: 4.8% | Rheumatism: 3.6% |
| Â | COPD: 11.4% | COPD: 13.1% | COPD: 10.7% | COPD: 7.4% |
| Â | Malignant tumour: 10.1% | Malignant tumour: 10.0% | Malignant tumour: 10.2% | Malignant tumour: 5.9% |
| Â | Kidney dysfunction: 6.0% | Kidney dysfunction: 8.9% | Kidney dysfunction: 4.6% | Kidney dysfunction: 2.0% |